In a second statement to the media since an advisory panel to the U.S. Food and Drug Administration (FDA) decided not to recommend approval of EDAP TMS’s outdated form of Ablatherm technology for the treatment of low-risk prostate cancer, the company’s CEO seems to exhibit serious misunderstandings about how to work with the FDA. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Ablatherm, approval, FDA, HIFU, high-intensity focused ultrasound | 22 Comments »
According to a report on the Bloomberg News web site, the FDA’s reviewers appear to be less than enthusiastic about the effectiveness and safety data submitted by EDAP TMS to support approval of the Ablatherm device for use of high-intensity focused ultrasound (HIFU) for the treatment of low-risk forms of prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: Ablatherm, HIFU, high-intensity focused ultrasound | Leave a comment »
In the UK, the team led by Drs Ahmed and Emberton has been meticulous in its collection and reporting of outcome data related to their investigational use of high-intensity focused ultrasound (HIFU) in the treatment of localized prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: HIFU, high-intensity focused ultrasound, outcome | 28 Comments »
In the UK, the National Institute for Clinical Excellence (NICE) has just published guidance on the use of focal forms of high-intensity focused ultrasound (HIFU) for the treatment of (low- and intermediate-risk forms of) localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: focal, guidance, HIFU, high-intensity focused ultrasound, NICE | 5 Comments »
We finally appear to have mid-term follow-up data from a sizeable series of North American patients with low- and intermediate-risk prostate cancer treated with first-line, high-intensity focused ultrasound (HIFU). The follow-up is limited to a median of 2 years, however, which allows projection of outcomes at 4 years. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: HIFU, high-intensity focused ultrasound, outcomes | Leave a comment »
A new paper by clinical researchers in Korea has concluded that treatment with high-intensity focused ultrasound (HIFU) “does not provide effective oncologic outcomes even in low risk patients with prostate cancer as well as in the intermediate or high risk groups,” but does have a low associated incidence of treatment complications. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: complications, first line, HIFU, high-intensity focused ultrasound, outcome | 7 Comments »
A new article reports data from two centers on experience with whole-gland high-intensity focused ultrasound (HIFU) salvage therapy for local recurrence following external beam radiation therapy (EBRT). .. READ MORE …
Filed under: Management, Treatment | Tagged: external beam radiation therapy, HIFU, high-intensity focused ultrasound, outcome, salvage | 4 Comments »
A second, small study has now offered additional data on clinical experience of the use of high-intensity focused ultrasound (HIFU) as a form of salvage therapy in men initially diagnosed with localized prostate cancer, but with a rising PSA after external beam radiation therapy (EBRT) as their first-line treatment. … READ MORE …
Filed under: Management, Treatment | Tagged: EBRT, external beam radiation, HIFU, high-intensity focused ultrasound, salvage | 12 Comments »
Men with locally recurrent prostate cancer after first-line external beam radiation therapy (EBRT) have historically had three options for second-line treatment: salvage radical prostatectomy, salvage cryoablation, and salvage brachytherapy. … READ MORE …
Filed under: Management, Treatment | Tagged: EBRT, external beam radiation therapy, HIFU, high-intensity focused ultrasound, QOL, quality of life, salvage | Leave a comment »
The potential of high-intensity focused ultrasound (HIFU) as a form of focal therapy for treatment of cancer isolated to a portion of the prostate as opposed to treatment of the entire prostate has been recognized for a considerable period of time. However, limited data are available so far on the outcomes of men treated with focal HIFU. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: complication, focal, HIFU, high-intensity focused ultrasound, outcome, recurrence | 5 Comments »
The presence of prostate cancer in the apex (the lowest tip) of the prostate is always a challenging aspect for treatment of localized prostate cancer, because this places the cancer close to the nerves that control erectile function (potency) and to the sphincter (valve) that controls urine flow. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: apex, HIFU, high-intensity focused ultrasound, localized, outcome, recurrence | 7 Comments »
An article in the April issue of Clinical Medical Insights: Oncology suggests that a rapid post-treatment increase in the PSA levels of men treated for localized prostate cancer with high-intensity focused ultrasound (HIFU) may indicate later risk for biochemical recurrence. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: HIFU, high-intensity focused ultrasound, progression, PSA, rapid, rise, risk | 3 Comments »
A media release issued by EDAP TMS SA — the developer and distributor of the Ablatherm® technology used in high-intensity focused ultrasound (HIFU) treatment of men with prostate cancer — states that a review of 15 years experience with Ablatherm technology will be published in the June issue of Current Urology Reports. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: Ablatherm, HIFU, high-intensity focused ultrasound, review | 2 Comments »
An early release paper in the Canadian Urological Association Journal offers information on a series of patients treated with external beam radiation therapy (EBRT) as salvage therapy after biochemical progression following high-intensity focused ultrasound (HIFU) as their first-line treatment. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: EBRT, external beam radiation therapy, HIFU, high-intensity focused ultrasound, salvage | Comments Off on EBRT as salvage therapy for refractory or progressive prostate cancer post-HIFU
Data from a series of Japanese patients continue to help us to understand the risks and benefits of first-line treatment with high-intensity focused ultrasound (HIFU) for men initially diagnosed with localized prostate cancer and followed for up to 7 years. … READ MORE …
Filed under: Management, Treatment | Tagged: HIFU, high-intensity focused ultrasound, localized | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 